A detailed history of Diversified Enterprises, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Diversified Enterprises, LLC holds 6,516 shares of NVO stock, worth $315,765. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,516
Previous 8,707 25.16%
Holding current value
$315,765
Previous $601 Million 39.83%
% of portfolio
0.02%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

SELL
$45.38 - $71.7 $99,427 - $157,094
-2,191 Reduced 25.16%
6,516 $362 Million
Q2 2025

Jul 16, 2025

BUY
$58.08 - $81.05 $37,055 - $51,709
638 Added 7.91%
8,707 $601 Million
Q1 2025

May 15, 2025

BUY
$69.3 - $90.95 $116,493 - $152,886
1,681 Added 26.31%
8,069 $560 Million
Q4 2024

Feb 10, 2025

BUY
$85.0 - $120.04 $14,620 - $20,646
172 Added 2.77%
6,388 $549 Million
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $740,139 - $903,930
6,216 New
6,216 $740 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Diversified Enterprises, LLC Portfolio

Follow Diversified Enterprises, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Enterprises, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Enterprises, LLC with notifications on news.